Cargando…
Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections
New oxazolidinones are in clinical development for the treatment of tuberculosis and nontuberculous mycobacterial (NTM) infections, as a replacement for linezolid and tedizolid, which cause mitochondrial toxicity after prolonged treatment. Here, we carried out side-by-side measurements of mitochondr...
Autores principales: | Negatu, Dereje A., Aragaw, Wassihun Wedajo, Cangialosi, Julianna, Dartois, Véronique, Dick, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112060/ https://www.ncbi.nlm.nih.gov/pubmed/36920191 http://dx.doi.org/10.1128/aac.01655-22 |
Ejemplares similares
-
Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus
por: Negatu, Dereje A., et al.
Publicado: (2023) -
Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice
por: Aragaw, Wassihun Wedajo, et al.
Publicado: (2022) -
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease
por: Negatu, Dereje A., et al.
Publicado: (2022) -
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021) -
Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus
por: Negatu, Dereje Abate, et al.
Publicado: (2021)